These findings provide significant insights into selecting the LINC00261/MiR105-5p/SELL signaling pathway as a new biomarker related to overall survival in HCC and may influence the effectiveness of HCC immunotherapy (67). The gene discussed is SELL; the disease is hepatocellular carcinoma.